Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile
Authors:
- Vittorio CanaleVCVittorio Canale
- Aleksandra RakARAleksandra Rak
- Magdalena KotańskaMKMagdalena Kotańska
- Joanna KnutelskaJKJoanna Knutelska
- Agata SiwekASAgata Siwek
- Marek BednarskiMBMarek Bednarski
- Leszek NowińskiLNLeszek Nowiński
- Małgorzata ZygmuntMZMałgorzata Zygmunt
- Paulina KoczurkiewiczPKPaulina Koczurkiewicz
- Elżbieta PękalaEPElżbieta Pękala
- Jacek SapaJSJacek Sapa
- Paweł ZajdelPZPaweł Zajdel
Open Access
Abstract
Benign prostatic hyperplasia (BPH) is the most common male clinical problem impacting the quality of life of older men. Clinical studies have indicated that the inhibition of α1A-/α1D adrenoceptors might offer effective therapy in lower urinary tract symptoms. Herein, a limited series of arylsulfonamide derivatives of (aryloxy)ethyl alicyclic amines was designed, synthesized, and biologically evaluated as potent α1-adrenoceptor antagonists with uroselective profile. Among them, compound 9 (3-chloro-2-fluoro-N-([1-(2-(2-(2,2,2-trifluoroethoxy)phenoxy]ethyl)piperidin-4-yl)methyl)benzenesulfonamide) behaved as an α1A-/α1D-adrenoceptor antagonist (Ki(α1) = 50 nM, EC50(α1A) = 0.8 nM, EC50(α1D) = 1.1 nM), displayed selectivity over α2-adrenoceptors (Ki(α2) = 858 nM), and a 5-fold functional preference over the α1B subtype. Compound 9 showed adequate metabolic stability in rat-liver microsome assay similar to the reference drug tamsulosin (Clint = 67 and 41 µL/min/mg, respectively). Compound 9 did not decrease systolic and diastolic blood pressure in normotensive anesthetized rats in the dose of 2 mg/kg, i.v. These data support development of uroselective agents in the group of arylsulfonamides of alicyclic amines with potential efficacy in the treatment of lower urinary tract symptoms associated to benign prostatic hyperplasia.Keywords
Funding Information
- Narodowe Centrum Nauki (2011/03/B/NZ7/00724)
This publication has 31 references indexed in Scilit:
- Prostatic α1‐adrenoceptors: New concepts of function, regulation, and intracellular signalingNeurourology and Urodynamics, 2013
- Role of 5-HT1Areceptors in control of lower urinary tract function in anesthetized ratsAmerican Journal of Physiology-Renal Physiology, 2010
- Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: A prospective randomized controlled studyInternational Journal of Urology, 2008
- α1‐Adrenoceptor subtypes and lower urinary tract symptomsInternational Journal of Urology, 2008
- Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in HepatocytesDrug Metabolism and Disposition, 2006
- Benign prostatic hyperplasia: age-related tissue-remodelingExperimental Gerontology, 2005
- Involvement of 5‐hydroxytryptamine (HT) 7 receptors in the 5‐HT excitatory effects on the rat urinary bladderBJU International, 2004
- α1-Adrenergic receptor subtypes: non-identical triplets with different dancing partners?Life Sciences, 2003
- TamsulosinDrugs, 1996
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973